Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons

Infection and Immunity

Volumn 64, Issue 2, 1996, Pages 677-679

  Paoletti, Lawrence C ^a,d   Kennedy, Ronald C ^b   Chanh, Tran C ^c   Kasper, Dennis L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ANTIBODY; BACTERIAL POLYSACCHARIDE; GLYCOCONJUGATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TETANUS TOXOID; VACCINE;

ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BABOON; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MOTHER; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; VACCINATION;

EID: 0030033274     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.2.677-679.1996     Document Type: Article

References (23)

1. Baker, C. J. 1980. Group B streptococcal infections. Adv. Intern Med. 25:475-501
2. Baker, C. J., M. S. Edwards, and D. L. Kasper. 1978. Immunogenicity of polysaccharides from type III. group B Streptococcus. J. Clin. Invest 61:1107-1110.
3. Baker, C. J., M. S. Edwards, and D. L. Kasper. 1981. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 68:544-549
4. Baker, C. J., and D. L. Kasper. 1976. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N. Engl. J Med 294:753-756.
5. Baker, C. J., and D. L. Kasper. 1985. Group B streptococcal vaccines. Rev Infect. Dis. 7:458-467
6. Baker, C. J., D. L. Kasper, I. B. Tager, A. Paredes, S. Alpert, W. M. McCormack, and D. Goroff. 1977. Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J. Clin. Invest. 59:810-818.
7. Baker, C. J., M. A. Rench, M. S. Edwards, R. J. Carpenter, B. M. Hays, and D. L. Kasper. 1988. Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus N. Engl J Med. 319:1180-1220.
8. Baltimore, R. S., D. L. Kasper, C. J. Baker, and D. K. Goroff. 1977 Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci J Immunol. 118:673-678.
9. Gupta, R. K., and G. R. Siber. 1995. Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 13:1263-1276.
10. Guttormsen, H.-K., C. J. Baker, M. S. Edwards, L. C. Paoletti, and D. L. Kasper. Quantitative determination of antibodies to type III group B streptococcal polysaccharide J. Infect. Dis., in press
11. Lagergard, T., J. Shiloach, J. B. Robbins, and R. Schneerson. 1990. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid. Infect Immun 58:687-694.
12. Madoff, L., L. Paoletti, J. Tai, and D. Kasper. 1994 Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J Clin Invest. 94:286-292.
13. Paoletti, L., M. Wessels, A. Rodewald, A. Shroff, H. Jennings, and D. Kasper. 1994. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect. Immun. 62:3236-3243.
14. Paoletti, L. C., D. L. Kasper, F. Michon, J. DiFabio, H. J. Jennings, T. D. Tosteson, and M. R. Wessels. 1992 Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J. Clin. Invest 89:203-2119.
15. Paoletti, L. C., M. R. Wessels, F. Michon, J. DiFabio, H. J. Jennings, and D. L. Kasper. 1992. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine Infect Immun. 60:4009-4014
16. Powell, M. F., J. L. Cleland, D. J. Eastman, A. Lim, M. J. Newman, J. H. Nunberg, R. P. Weissburg, J. C. Vennari, T. Wrin, and P. W. Berman. 1994. Immunogenicity and HIV-1 virus neutralization of MN recombinant glycoprotein 120/HIV-1 QS21 vaccine in baboons AIDS Res Hum. Retroviruses 10:8105-8108
17. Schuchat, A., and J. D. Wenger. 1994. Epidemiology of group B streptococcal disease. Risk factors, prevention strategy, and vaccine development Epidemiol Rev 16:374-402
18. Shearer, M. H., H. B. Jenson, K. D. Carey, T. C. Chanh, and R. C. Kennedy. 1994 Production and characterization of murine monoclonal antibodies specific for baboon IgG heavy and light chain epitopes J Med. Primatol, 23:382-387.
19. Shearer, M. H., F. J. Stevens, F. H. Westhold, H. B. Jenson, T. C. Chanh, K. D. Carey, G. L. White, A. Solomon, and R. C. Kennedy. Serologic cross-reactions among primate immunoglobulins. Dev Comp. Immunol., in press.
20. Wessels, M. R., L. C. Paoletti, D. L. Kasper, J. L. DiFabio, F. Michon, K. Holme, and H. J. Jennings. 1990. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J. Clin Invest. 86:1428-1433.
21. Wessels, M. R., L. C. Paoletti, J. Pinel, and D. L. Kasper. 1995. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J. Infect Dis. 171:879-884.
22. Wessels, M. R., L. C. Paoletti, A. K. Rodewald, F. Michon, J. DiFabio, H. J. Jennings, and D. L. Kasper. 1993. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine Infect. Immun. 61:4760-4766.
23. Wessels, M. R., V. Pozsgay, D. L. Kasper, and H. J. Jennings. 1987 Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus A revised structure for the type III group B streptococcal polysaccharide antigen. J. Biol. Chem 262: 8262-8267